A 12-week TRE protocol (6h window) is being tested for early Huntington’s Disease, showing potential benefits for mitochondrial function and autophagy with 80% adherence expected. New clinical t...
A 12-week clinical trial explores time-restricted eating’s potential to enhance mitochondrial function and reduce oxidative stress in early-stage Huntington’s disease. A new clinical trial inv...
Johns Hopkins Hospital’s pilot study reveals ADAM sensors with AI biofeedback improve swallow frequency by 45%, reducing aspiration pneumonia risk by 32%, now under FDA fast-track review. Breakt...
A 12-week clinical trial explores time-restricted eating’s effects on cognitive function and mitochondrial health in Huntington’s disease patients. New research investigates whether time-restr...
New clinical trial explores time-restricted eating’s potential benefits for Huntington’s disease patients, focusing on metabolic health and symptom management. A groundbreaking clinical tr...
A recent PLoS One study reveals that a 12-week time-restricted eating protocol improves mitochondrial function and reduces polyQ aggregation in Huntington’s disease patients. Groundbreaking rese...
Recent studies suggest time-restricted eating may offer neuroprotective benefits for Huntington’s disease by improving mitochondrial function and reducing oxidative stress. Emerging research indicat...
A 12-week clinical trial investigates time-restricted eating’s safety and efficacy in early-stage Huntington’s disease, focusing on mitochondrial function and cognitive outcomes. Groundbre...
New research explores how fasting may improve mitochondrial function and reduce oxidative stress in Huntington’s disease, with implications for other neurodegenerative conditions. Recent clinica...
Exploring a 12-week clinical trial protocol for time-restricted eating in early-stage Huntington’s disease, focusing on mitochondrial function, autophagy, and cognitive improvements. A new 12-we...
